Sun Pharma Corporate Overview

Consistent profitability and returns Gross Margin # EBITDA Margin 73.8% 72.6% 71.5% 71.4% 20.7% 19.9% 20.0% SUN PHARMA 24.5% Net Margin (adjusted) 17.9% 13.5% 12.7% 12.5% FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21 ROCE ROE Market Cap (USD Bn) 13.5% 11.8% 11.1% 11.0% II 9.4% 8.7% 9.1% 12.5% 18.3 16.6 11.9 19.3 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21 FY18 FY19 FY20 FY21 # Gross margin= (Net Sales - Material Cost)/ Net Sales*100 ROCE & ROE exclude one-time exceptional charges ROCE = EBIT / Avg. (Total Assets - Current Liabilities) ROE = Net Profit / Avg. Shareholders Equity © Sun Pharmaceutical Industries Limited. All Rights Reserved. (Market Cap as on 31st March) 12

View entire presentation